In Brief: Arkansas ephedrine rule
This article was originally published in The Tan Sheet
Executive Summary
Arkansas ephedrine rule: The Arkansas Department of Health's proposal to restrict sale of OTC ephedrine (including d-pseudoephedrine and Ma Huang) has been delayed. Arkansas Health Department Counsel George Harper notified the agency in a Sept. 8 letter that changes in the wording of the proposal necessitate a re-review. He noted, however, that "should there be a need to expedite the implementation of this rulemaking, it is permissible for the state board of health to adopt emergency rules and regulations under certain specified conditions." That possibility may be addressed at a board of health meeting in October...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning